Uncategorized
Where MasterCraft Boat Hldgs Stands With Analysts
Latest Ratings for MCFT Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Nov 2021 Raymond James Maintains Outperform May 2021 Raymond James Maintains Outperform View More Analyst Ratings for MCFT View the Latest Analyst Ratings read more
Taiwan Semi and GlobalFoundries Finalize Major US Funding Deals, Eye Growth in Chip Manufacturing
Prominent chipmakers, including Taiwan Semiconductor Manufacturing Co (NYSE:TSM) and GlobalFoundries Inc (NASDAQ:GFS), have finalized agreements for substantial U.S. read more
EPAM Q3 Earnings: Beats Expectations, Rising Margins, CEO Flags NEORIS Acquisition
EPAM Systems reported Q3 sales of $1.17 billion, beating analyst estimate of $1.15B. Adjusted EPS of $3.12 also beat consensus of $2.70. read more
Steve Madden Q3 Earnings Top Estimates As Revenue Jumps 13%, Lifts 2024 Outlook
Steven Madden, Ltd. (NASDAQ: SHOO) reported higher Q3 revenues, direct-to-consumer sales, and approved a dividend. FY24 guidance raised. read more
Under Armour CEO Signals ‘Premium’ Brand Transformation After Strong Q2 Performance, Stock Soars
Under Armour reported better-than-expected Q2 2025 results, with revenue declining 10.7% and adjusted EPS of $0.30. The company raised its full-year outlook, leading to a jump in its stock price. read more
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Aurora’s international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter. read more
Compounded Versions Of Weight Loss And Diabetes Drugs Led To Death And Hospitalization, Novo Nordisk Says It Is Aware
Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the FDA to resolve issues. read more